---
schema_version: "secwatch.filing_event.v1"
accession: "0001321732-21-000106"
form_type: "8-K"
ticker: "PEN"
cik: "0001321732"
company_name: "Penumbra Inc"
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T13:46:03.072965+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Penumbra Q3 revenue $190.1M (+26%), swings to operating profit; raises FY guidance

## Summary
- Revenue $190.1M, +25.8% YoY (+25.6% constant currency); US 71%, international 29%.
- Vascular segment $105.5M (+40.3%); Neuro segment $84.7M (+11.5%).
- Gross margin 63.1% vs 60.2%; operating income $8.8M vs loss of $20.2M a year ago.
- Full-year 2021 revenue guidance raised to $735M-$740M from prior $720M-$730M.
- R&D expense fell to $16.7M from $34.9M; SG&A rose to $94.4M from $76.2M.

## SEC filing metadata
- accession: 0001321732-21-000106
- form_type: 8-K
- ticker: PEN
- cik: 0001321732
- company_name: Penumbra Inc
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321732/000132173221000106/0001321732-21-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321732/000132173221000106/pen-20211103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001321732-21-000106
- JSON: https://secwatch.observer/filing/0001321732-21-000106.json
- Plain text: https://secwatch.observer/filing/0001321732-21-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.